Mersana Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. 

CEO
Martin H. Huber
CEOMartin H. Huber
Employees
102
Employees102
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2001
Founded2001
Employees
102
Employees102

MRSN Key Statistics

Market cap
45.12M
Market cap45.12M
Price-Earnings ratio
-0.60
Price-Earnings ratio-0.60
Dividend yield
Dividend yield
Average volume
4.07M
Average volume4.07M
High today
$0.381
High today$0.381
Low today
$0.3502
Low today$0.3502
Open price
$0.363
Open price$0.363
Volume
2.44M
Volume2.44M
52 Week high
$2.83
52 Week high$2.83
52 Week low
$0.2589
52 Week low$0.2589

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own MRSN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.